Kiva KIV2200Recalls & reported problems
Benvenue Medical, Inc. · Kiva VCF Treatment System, First Fracture Kit, Left · Class 2 · Implant
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00813478020025), received between Sep 30, 2015 and Sep 30, 2015 — classified as 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Bone Fracture(s)1
- Pain1
- Paralysis1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjurySep 30, 2015Adverse Event Without Identified Device or Use Problem
THIS EVENT IS FILED TO REPORT A RE-FRACTURE AT THE TREATED LEVEL OBSERVED 21 DAYS POST PROCEDURE, WHICH SUBSEQUENTLY REQUIRED SURGICAL INTERVENTION. THE T6 LEVEL WAS TREATED WITH KIVA VIA THE LEFT PEDICLE WITH ABOUT 2 LOOPS OF IMPLANT AND 1CC OF CEMENT VOLUME. THERE WERE NO ISSUES WITH THE DEVICE, AND NO PATIENT COMPLICATION WAS REPORTED DURING THE KIVA PROCEDURE. THE PROCEDURE WAS CONSIDERED UNEVENTFUL AND SUCCESSFUL BY THE TREATING PHYSICIAN. THE PATIENT WAS RELEASED THEREAFTER AND INDICATED PAIN IMPROVEMENT ON THE FIRST PHONE FOLLOW-UP APPROXIMATELY ONE WEEK POST KIVA PROCEDURE. 21 DAYS POST PROCEDURE ON (B)(6) 2015, THE PATIENT CAME BACK WITH BACK PAIN AND CT IMAGING IDENTIFIED A RE-FRACTURE AT THE INDEX LEVEL, WHICH WAS TREATED ACCORDINGLY WITH PAIN MEDICATION, AND SUBSEQUENTLY RELEASED. LATE AUGUST/EARLY (B)(6), THE PATIENT CAME BACK TO THE HOSPITAL, NOW UNABLE TO MOVE HER LEGS AND HAD LITTLE SENSATION IN THEM. UPON FURTHER CT IMAGING, THE INDEX LEVEL SUFFERED AN APPARENT BURST FRACTURE. EVIDENCE OF BONE REABSORPTION FROM LUCENCY SURROUNDING THE IMPLANT WAS SEEN, AS MENTIONED BY THE PHYSICIAN. THE PATIENT UNDERWENT AN UNCOMPLICATED DECOMPRESSION PROCEDURE ON (B)(6) 2015 TO PR
Patient problems: Bone Fracture(s); Pain; Paralysis
MAUDE report 5115547 ↗
Other Bone Cement devices
- SMARTSET 3122-040Depuy (Ireland) · BONE CEMENT824 reports
- NA 3322-020Depuy (Ireland) · BONE CEMENT306 reports
- NA 3312-040Depuy (Ireland) · BONE CEMENT4 deaths258 reports
- NA 3332-040Depuy (Ireland) · BONE CEMENT4 deaths197 reports
- NA 5450-31-500Depuy (Ireland) · BONE CEMENT2 deaths168 reports
- NA 5450-32-500Depuy (Ireland) · BONE CEMENT1 death150 reports
- PALACOS® MV pro 80Heraeus Medical GmbH · Bone Cement2 recalls1 report
- PALACOS® R pro 80Heraeus Medical GmbH · Bone Cement2 recalls1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page